Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Conventional Analgesia for PCNL
NCT06935006Not yet recruiting
- Sponsor
- Sohag University
- Start
- May 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoint: Reduction of postoperative pain at 1 year. Planned start May 2025; status: not yet recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06935006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06935006.